Microglial NF-κB drives tau spreading and toxicity in a mouse model of tauopathy. Academic Article uri icon

Overview

abstract

  • Activation of microglia is a prominent pathological feature in tauopathies, including Alzheimer's disease. How microglia activation contributes to tau toxicity remains largely unknown. Here we show that nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) signaling, activated by tau, drives microglial-mediated tau propagation and toxicity. Constitutive activation of microglial NF-κB exacerbated, while inactivation diminished, tau seeding and spreading in young PS19 mice. Inhibition of NF-κB activation enhanced the retention while reduced the release of internalized pathogenic tau fibrils from primary microglia and rescued microglial autophagy deficits. Inhibition of microglial NF-κB in aged PS19 mice rescued tau-mediated learning and memory deficits, restored overall transcriptomic changes while increasing neuronal tau inclusions. Single cell RNA-seq revealed that tau-associated disease states in microglia were diminished by NF-κB inactivation and further transformed by constitutive NF-κB activation. Our study establishes a role for microglial NF-κB signaling in mediating tau spreading and toxicity in tauopathy.

authors

  • Wang, Chao
  • Fan, Li
  • Khawaja, Rabia R
  • Liu, Bangyan
  • Zhan, Lihong
  • Kodama, Lay
  • Chin, Marcus
  • Li, Yaqiao
  • Le, David
  • Zhou, Yungui
  • Condello, Carlo
  • Grinberg, Lea T
  • Seeley, William W
  • Miller, Bruce L
  • Mok, Sue-Ann
  • Gestwicki, Jason E
  • Cuervo, Ana Maria
  • Luo, Wenjie
  • Gan, Li

publication date

  • April 12, 2022

Research

keywords

  • Microglia
  • NF-kappa B
  • Tauopathies
  • tau Proteins

Identity

PubMed Central ID

  • PMC9005658

Scopus Document Identifier

  • 85128156366

Digital Object Identifier (DOI)

  • 10.1038/s41467-022-29552-6

PubMed ID

  • 35413950

Additional Document Info

volume

  • 13

issue

  • 1